BIRO Report site: 319761ea64b939fa1be95f0c7eb6e8c07691f006
Reference date: 18/02/12
Parameter: 5.2.14 Percentage of adults w lipid lowering treatment
Lipid lowering treatment Valid Value (%) NV/NA (%)
Valid Value 133525 (  83.4) 0 (    0.0) 133525 (  83.4)
NV/NA 26529 (  16.6) 0 (    0.0) 26529 (  16.6)
160054 (100.0) 0 (    0.0) 160054 (100.0)
Table 5.2.14.1 : Lipid lowering treatment (by Type of Diabetes)

CMH Chi-Square p.value df
71526.7598 0 1






Barplot 5.2.14.1 - Lipid lowering treatment (by Type of Diabetes)


Lipid lowering treatment Type 1 (%) Type 2 (%)
Yes 3300 (  26.6) 57668 (  47.6) 60968 (  45.7)
No 9129 (  73.4) 63428 (  52.4) 72557 (  54.3)
12429 (    9.3) 121096 (  90.7) 133525 (100.0)
Table 5.2.14.2 : Lipid lowering treatment (by Type of Diabetes)

CMH Chi-Square p.value df
2016.1886 0 1






Barplot 5.2.14.2 - Lipid lowering treatment (by Type of Diabetes)








Barplot 5.2.14.2a - Lipid lowering treatment (by Data Source, Type of Diabetes = Type 1)








Barplot 5.2.14.2b - Lipid lowering treatment (by Data Source, Type of Diabetes = Type 2)




s O E N CR AR C.I. (95%) [O-E]/E % C.I. [O-E]/E (95%)
01 12 4 29 41.4 79.7 ( 52.5;100.0) 200.0 ( 3.5;396.5)
08 74 53 183 40.4 37.1 ( 31.5; 42.6) 39.6 ( 20.4; 58.8)
12 1194 943 3317 36.0 33.6 ( 32.3; 34.9) 26.6 ( 21.9; 31.3)
18 106 90 236 44.9 31.3 ( 27.1; 35.4) 17.8 ( 6.9; 28.7)
19 341 296 1157 29.5 30.6 ( 28.2; 33.0) 15.2 ( 5.8; 24.6)
06 50 48 214 23.4 27.7 ( 21.3; 34.0) 4.2 (-24.1; 32.4)
17 570 659 2528 22.5 23.0 ( 21.4; 24.6) -13.5 (-19.7; -7.4)
10 232 286 967 24.0 21.5 ( 19.2; 23.9) -18.9 (-26.9;-10.8)
04 721 913 3768 19.1 21.0 ( 19.6; 22.3) -21.0 (-26.7;-15.3)
T 3300 12399 26.6
Table 5.2.14.3 - Standardized Estimates: 5.2.14 Percentage of adults w lipid lowering treatment (Type of Diabetes = Type 1 )





Barplots (Adjusted Rates): 5.2.14.1 5.2.14 Percentage of adults w lipid lowering treatment - Type of Diabetes = Type 1








Forest plots: 5.2.14.1 5.2.14 Percentage of adults w lipid lowering treatment - Type of Diabetes = Type 1


s O E N CR AR C.I. (95%) [O-E]/E % C.I. [O-E]/E (95%)
01 341 227 469 72.7 71.5 ( 67.1; 76.0) 50.2 ( 41.1; 59.4)
13 3396 2307 4884 69.5 70.1 ( 68.7; 71.5) 47.2 ( 44.2; 50.2)
19 1670 1151 2457 68.0 69.1 ( 67.1; 71.1) 45.1 ( 40.8; 49.3)
12 5028 3527 7176 70.1 67.9 ( 66.8; 69.0) 42.6 ( 40.3; 44.8)
18 3776 3466 7422 50.9 51.9 ( 50.7; 53.0) 8.9 ( 6.5; 11.4)
06 2646 2463 5016 52.8 51.2 ( 49.8; 52.5) 7.4 ( 4.7; 10.1)
08 564 535 1142 49.4 50.2 ( 47.3; 53.1) 5.4 ( -0.8; 11.6)
10 3881 3768 7967 48.7 49.0 ( 48.0; 50.1) 3.0 ( 0.7; 5.3)
09 614 624 1306 47.0 46.9 ( 44.2; 49.5) -1.6 ( -7.2; 4.0)
17 21790 23831 50927 42.8 43.5 ( 43.1; 44.0) -8.6 ( -9.5; -7.6)
04 13962 15764 32330 43.2 42.2 ( 41.6; 42.7) -11.4 (-12.5;-10.3)
T 57668 121096 47.6
Table 5.2.14.4 - Standardized Estimates: 5.2.14 Percentage of adults w lipid lowering treatment (Type of Diabetes = Type 2 )





Barplots (Adjusted Rates): 5.2.14.2 5.2.14 Percentage of adults w lipid lowering treatment - Type of Diabetes = Type 2








Forest plots: 5.2.14.2 5.2.14 Percentage of adults w lipid lowering treatment - Type of Diabetes = Type 2